QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
QQQ   414.65 (-2.07%)
AAPL   165.00 (-1.22%)
MSFT   399.12 (-1.27%)
META   481.07 (-4.13%)
GOOGL   154.09 (-1.23%)
AMZN   174.63 (-2.56%)
TSLA   147.05 (-1.92%)
NVDA   762.00 (-10.00%)
AMD   146.64 (-5.44%)
NIO   3.80 (-5.00%)
BABA   69.07 (+0.28%)
T   16.51 (+1.10%)
F   12.14 (+0.66%)
MU   106.77 (-4.61%)
GE   148.06 (-3.19%)
CGC   7.93 (+1.28%)
DIS   112.61 (+0.16%)
AMC   3.16 (+8.22%)
PFE   26.00 (+2.40%)
PYPL   62.31 (+0.34%)
XOM   119.88 (+1.15%)
Free Trial
NASDAQ:CYRN

Cyren (CYRN) Stock Price, News & Analysis

→ The #1 Opportunity of the decade? (From Behind the Markets) (Ad)
Free CYRN Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
N/A
50-Day Range
$0.21
▼
$0.92
52-Week Range
N/A
Volume
1.15 million shs
Average Volume
1.43 million shs
Market Capitalization
$1.70 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
CYRN stock logo

About Cyren Stock (NASDAQ:CYRN)

CYREN Ltd. engages in the provision of cloud delivered Software-as-a-Service cybersecurity solutions that protect businesses, employees and customers against threats from email, files, and the web. It operates through the following geographical segments: Israel, United States, Germany and Other. Its products include inbox security for office 365, threat indepth, and incident response service The company was founded by Amir Lev, Gideon Mantel, and Nahum Sharfman on February 10, 1991 and is headquartered in Herzliya, Israel.

CYRN Stock News Headlines

May 16, 2023 | marketwatch.com
TechMediaBreaks - Data443 Risk Mitigation Inc. (ATDS) Announces Strategic Acquisition of Select Assets of Israel-Based Cyren Ltd.
February 23, 2023 | investorplace.com
Why Is Cyren (CYRN) Stock Down 27% Today?
April 19, 2024 | Behind the Markets (Ad)
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
February 22, 2023 | finance.yahoo.com
Cyren Announces Nasdaq Delisting Determination
February 22, 2023 | finance.yahoo.com
Cyren Announces Liquidation
February 22, 2023 | investorplace.com
Why Is Cyren (CYRN) Stock Up 43% Today?
February 21, 2023 | finance.yahoo.com
Cyren Announces Non-Binding LOI to Sell Iceland-Based Anti-Malware Business Assets
February 16, 2023 | tmcnet.com
NetSTAR Offers a Threat Intelligence Feed Replacement for Cyren's OEM Customers
April 19, 2024 | Behind the Markets (Ad)
Tiny Biotech Stock Wins $75 Billion Patent
A little-known biotech has been quietly working on revolutionary treatments for neurodegenerative diseases. Most people have never heard of them... but those in the know have been taking notice. Jeff Bezos cut them a check for $130 million. Fidelity Biosciences for a further $217 million. They've even had several collaborative partnerships with much larger companies like Biogen, Sanofi, and Takeda.
February 1, 2023 | finance.yahoo.com
Cyren Announces Global Reduction in Force; Liquidity Challenges
January 22, 2023 | bbc.com
Rutter points to Marsch influence
November 16, 2022 | finanznachrichten.de
Cyren Ltd: Cyren Announces Third Quarter 2022 Financial Results
November 16, 2022 | apnews.com
Cyren: Q3 Earnings Snapshot
November 16, 2022 | seekingalpha.com
Cyren Ltd (CYRN) Q3 2022 Earnings Call Transcript
November 15, 2022 | finance.yahoo.com
Cyren Announces Third Quarter 2022 Financial Results
November 9, 2022 | reuters.com
CYRN.A - Cyren Ltd | Stock Price & Latest News | Reuters
November 2, 2022 | finance.yahoo.com
Cyren Schedules Third Quarter 2022 Earnings Release for Monday, November 14, 2022
October 24, 2022 | reuters.com
CYRN.PH - Cyren Ltd | Stock Price & Latest News | Reuters
October 19, 2022 | benzinga.com
Foretrace Appoints Industry Veteran as President and COO - CYREN (NASDAQ:CYRN) - Benzinga
October 10, 2022 | seekingalpha.com
SOBR Safe tops tech gainers; ACM Research tops losers - Seeking Alpha
October 8, 2022 | streetinsider.com
eSentire Adds Cybersecurity Industry Heavyweights to its Board of Directors - StreetInsider.com
September 22, 2022 | marketscreener.com
Cyren : Statement of Changes in Beneficial Ownership - Form 4 - Marketscreener.com
September 15, 2022 | streetinsider.com
Cyren Launches Hybrid Analyzer for Unmatched Speed and Scale of Malware Analysis - StreetInsider.com
September 13, 2022 | finance.yahoo.com
Cyren Launches Hybrid Analyzer for Unmatched Speed and Scale of Malware Analysis
September 6, 2022 | marketscreener.com
CYREN LTD. : Submission of Matters to a Vote of Security Holders (form 8-K) - Marketscreener.com
August 17, 2022 | finance.yahoo.com
Cyren Inbox Security Achieves SOC 2 Type 2 Compliance
August 16, 2022 | finance.yahoo.com
Cyren Announces Second Quarter 2022 Financial Results
See More Headlines
Receive CYRN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cyren and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/15/2021
Today
4/19/2024
Fiscal Year End
12/31/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Computer and Technology
Industry
Prepackaged software
Sub-Industry
N/A
Current Symbol
NASDAQ:CYRN
CUSIP
N/A
CIK
1084577
Web
www.cyren.com
Phone
(729) 863-6888
Fax
972-9894-8214
Employees
200
Year Founded
1991

Profitability

EPS (Most Recent Fiscal Year)
($5.34)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-23,040,000.00
Net Margins
-123.96%
Pretax Margin
-94.37%
Return on Equity
-206.16%
Return on Assets
-48.72%

Debt

Debt-to-Equity Ratio
2.30
Current Ratio
1.29
Quick Ratio
1.29

Sales & Book Value

Annual Sales
$31.19 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$3.05 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
7,780,000
Free Float
7,539,000
Market Cap
$1.70 million
Optionable
Not Optionable
Beta
0.83

Social Links

Ten Starter Stocks For Beginners to Buy Now Cover
Ten Starter Stocks For Beginners to Buy Now

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Key Executives

Key Competitors

View All Competitors

CYRN Stock Analysis - Frequently Asked Questions

How were Cyren's earnings last quarter?

Cyren Ltd. (NASDAQ:CYRN) issued its quarterly earnings data on Monday, November, 15th. The technology company reported ($0.06) EPS for the quarter, hitting the consensus estimate of ($0.06). The technology company had revenue of $7.46 million for the quarter. Cyren had a negative net margin of 123.96% and a negative trailing twelve-month return on equity of 206.16%.

What other stocks do shareholders of Cyren own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cyren investors own include Actinium Pharmaceuticals (ATNM), Inovio Pharmaceuticals (INO), Onconova Therapeutics (ONTX), OPKO Health (OPK), Vaxart (VXRT), Biocept (BIOC), iBio (IBIO), MEI Pharma (MEIP), VBI Vaccines (VBIV) and

Does Cyren have any subsidiaries?
The following companies are subsidiares of Cyren: Authentium, Cyren Gesellschaft mbH, Cyren Iceland hf, Cyren Inc., Cyren UK Ltd., FRISK Software International, Wingtra, and eleven GmbH.
Read More
This page (NASDAQ:CYRN) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners
The Best AI Stock to Own in the World Today is Trading for Just $25
Banyan Hill Publishing
The “Perfect Storm” for Gold
Gold Safe Exchange
Tiny Biotech Stock Wins $75 Billion Patent
Behind the Markets
Biden’s $374B Giveaway Into This Sector
DTI
He Is Giving Away Bitcoin
Crypto Swap Profits
The "Smart Money" Is Ready for May 1st Are You?
Stansberry Research
The #1 Crypto for 2024
InvestorPlace
Your Money is Not Safe
American Alternative